SCHEMBL20135363

SCHEMBL20135363

Cc1ccc(-n2cc(C3CCN(C(=O)c4ccc(C5(C)NC(=O)NC5=O)cc4)CC3)nn2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
UBE2M P61081 1/20 0.39
DCUN1D1 Q96GG9 1/20 0.39
HPGD P15428 2/20 0.39
ALDH1A1 P00352 1/20 0.39
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
MIF P14174 1/20 0.38
MAPK7 Q13164 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
CRBN Q96SW2 2/20 0.37
TP53 P04637 1/20 0.36
HSD11B1 P28845 1/20 0.36
MGLL Q99685 1/20 0.36
PKM P14618 1/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
CA9 Q16790 2/20 0.35
CA12 O43570 1/20 0.35
USP2 O75604 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20135362 1.00 UBE2M (0.39) UBE2MDCUN1D1HPGDALDH1A1MEN1
SCHEMBL20135224 0.88 ADAMTS5 (0.38) UBE2MDCUN1D1HPGDALDH1A1MEN1
SCHEMBL20135225 0.88 ADAMTS5 (0.38) UBE2MDCUN1D1HPGDALDH1A1MEN1
SCHEMBL20134970 0.84 MGLL (0.39) UBE2MDCUN1D1HPGDALDH1A1MEN1
SCHEMBL20134774 0.84 UBE2M (0.39) UBE2MDCUN1D1MEN1KMT2AMAPK7
SCHEMBL20134973 0.84 MGLL (0.39) UBE2MDCUN1D1HPGDALDH1A1MEN1
SCHEMBL20134773 0.84 UBE2M (0.39) UBE2MDCUN1D1MEN1KMT2AMAPK7
SCHEMBL20134794 0.82 MEN1 (0.39) UBE2MDCUN1D1HPGDALDH1A1MEN1
SCHEMBL20134792 0.82 MEN1 (0.39) UBE2MDCUN1D1HPGDALDH1A1MEN1
SCHEMBL20791691 0.79 UBE2M (0.40) UBE2MDCUN1D1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3321256-A1 NOVEL IMIDE DERIVATIVES AND USE THEREOF AS MEDICINE Mitsubishi Tanabe Pharma Corporation (JP) 2018-05-16 EP disclosed